Literature DB >> 20694281

Evolution of untreated calf deep-vein thrombosis in high risk symptomatic outpatients: the blind, prospective CALTHRO study.

Gualtiero Palareti1, Benilde Cosmi, Gianfranco Lessiani, Giuseppina Rodorigo, Giuliana Guazzaloca, Carlotta Brusi, Lelia Valdré, Eleonora Conti, Michelangelo Sartori, Cristina Legnani.   

Abstract

The natural history of calf deep-vein thrombosis (DVT) is still uncertain and it is debated whether it warrants to be diagnosed and treated. We aimed to investigate the complication rate of untreated isolated calf DVT (ICDVT). Symptomatic outpatients were prospectively managed with serial compression ultrasonography (SCUS). Those without proximal DVT and with likely pre-test clinical probability (PCP) or altered D-dimer received immediate subsequent complete examination of calf deep veins (CCUS) by a different operator. The result of CCUS was kept blind both to the managing doctor and the patient and disclosed after three months. Primary outcome was the rate of venous thromboembolism at three months. We examined 431 subjects (196 males; median age 68.0 years) in whom five outcomes were recorded (1.2%; 95% confidence intervals [CI]: 0.4-2.7). If CCUS results had been available, outcomes would have been recorded in 3/424 patients (0.7%; 95% CI: 0.2-2.1) with two events in subjects negative at both serial and complete CUS. ICDVT was diagnosed in 65 subjects (15.3%; 95% CI: 12-19); of whom 59 remained uneventful (one was lost to follow-up). A significant higher rate of outcomes was recorded in subjects with than without ICDVT (5/64; 7.8%; 95% CI: 3-17 vs. 3/351; 0.8%; 95% CI: 0-2; p=0.003). However, after excluding two events picked at serial CUS in subjects with ICDVT, the difference became barely significant (3/64; 4.7%; 95% CI: 1-13; p=0.049). Thrombotic evolution of untreated ICDVT in high-risk subjects may be relevant. Larger studies are needed to address this issue.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20694281     DOI: 10.1160/TH10-06-0351

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  23 in total

Review 1.  Lower-extremity venous ultrasound - past, present and future.

Authors:  Rachelle Goldfisher
Journal:  Pediatr Radiol       Date:  2017-08-04

2.  Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Roman Jaeschke; Scott M Stevens; Steven Goodacre; Philip S Wells; Matthew D Stevenson; Clive Kearon; Holger J Schunemann; Mark Crowther; Stephen G Pauker; Regina Makdissi; Gordon H Guyatt
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  Do isolated calf deep vein thrombosis need anticoagulant treatment?

Authors:  Gualtiero Palareti
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

5.  Isolated calf deep vein thrombosis in the community setting: the Worcester Venous Thromboembolism study.

Authors:  Frederick A Spencer; Aimee Kroll; Darleen Lessard; Cathy Emery; Alla V Glushchenko; Luigi Pacifico; George Reed; Joel M Gore; Robert J Goldberg
Journal:  J Thromb Thrombolysis       Date:  2012-04       Impact factor: 2.300

6.  Bevacizumab Plus Direct Oral Anticoagulant Therapy in Ovarian Cancer Patients with Distal Deep Vein Thrombosis.

Authors:  Shinichi Komiyama; Masaru Nagashima; Tomoko Taniguchi; Takayuki Rikitake; Mineto Morita
Journal:  Clin Drug Investig       Date:  2019-04       Impact factor: 2.859

Review 7.  Should we diagnose and treat distal deep vein thrombosis?

Authors:  Helia Robert-Ebadi; Marc Righini
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 8.  Guidance for the treatment of deep vein thrombosis and pulmonary embolism.

Authors:  Michael B Streiff; Giancarlo Agnelli; Jean M Connors; Mark Crowther; Sabine Eichinger; Renato Lopes; Robert D McBane; Stephan Moll; Jack Ansell
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

9.  Prevalence of Acute Deep Vein Thrombosis in Patients with Ankle and Foot Fractures Treated with Nonoperative Management-A Pilot Study.

Authors:  Edward Ho; Abdullah Omari
Journal:  Int J Angiol       Date:  2015-07-10

Review 10.  Controversies in venous thromboembolism: the unique case of isolated distal deep vein thrombosis.

Authors:  Angelo Porfidia; Annamaria Carnicelli; Nicola Bonadia; Roberto Pola; Raffaele Landolfi
Journal:  Intern Emerg Med       Date:  2016-04-28       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.